Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 239 record(s)

Req # A-2019-001747

All correspondence with the Minister of Health and Deputy Minister Stephen Lucas, between November 2019 and January 2020, excluding letters from the public, regarding the national dental care plan.

Organization: Health Canada

15 page(s)
September 2021

Req # A-2019-001996

The "Ready to Build" letters, if applicable, that would have been sent to the below identified licenced producers of medical marijuana under the authority of the (then) Marijuana for Medical Purposes Regulations (MMPR since repealed). Aurora Cannabis licenced Feb 20, 2015, Aphria Inc licenced Mar 24, 2014, Tweed/Canopy Growth licenced Aug 8, 2014, MedReleaf licenced Feb 14, 2014, RedeCan licenced June 6, 2014, Peace Naturals Project Inc licenced Oct 31, 2013, Starsee Medicinal licenced Nov 1, 2013.

Organization: Health Canada

17 page(s)
September 2021

Req # A-2020-000465

Adverse Reaction Reports (AERs). Report numbers: E2B_02590570, E2B_02445649, E2B_02474428, E2B_02474529, E2B_02500218, E2B_02503231, E2B_02503569, E2B_02504419, E2B_02510541, E2B_02519200, E2B_02524146, E2B_02524346, E2B_02527704, E2B_02532286, E2B_02534176, E2B_02560516, E2B_02576066, E2B_02576617, E2B_02608910, E2B_02611425.

Organization: Health Canada

188 page(s)
September 2021

Req # A-2020-000498

Adverse Reaction Reports (AERs). Report numbers: E2B_03012755, E2B_02900556, E2B_02803753, E2B_03031486, E2B_02832171, E2B_02784536.

Organization: Health Canada

65 page(s)
September 2021

Req # A-2020-000575

Adverse Reaction Reports (AERs). Report numbers: 000733028, 000732802, 000619318, E2B_01480563, E2B_02831793, E2B_02839759, E2B_02840136, 000736688, E2B_02954367.

Organization: Health Canada

91 page(s)
September 2021

Req # A-2020-000619

Adverse Reaction Reports (AERs). Report numbers: E2B_03056590, E2B_03056592, E2B_03069154, E2B_03070776.

Organization: Health Canada

73 page(s)
September 2021

Req # A-2020-000620

Adverse Reaction Reports (AERs). Report numbers: E2B_03074640, E2B_03074834, E2B_03077865.

Organization: Health Canada

40 page(s)
September 2021

Req # A-2020-000630

Electronic versions of the reviewer reports for the approval of Effexor.

Organization: Health Canada

0 page(s)
September 2021

Req # A-2020-000704

Electronic versions of the reviewer reports for the approval of Cipralex.

Organization: Health Canada

0 page(s)
September 2021

Req # A-2020-000949

All Canadian reports on undesirable events regarding Elmiron.

Organization: Health Canada

631 page(s)
September 2021
Date modified: